Summary
BACKGROUND: Guidelines for prevention of venous thromboembolism recognize pneumonia and changes in respiratory status as risk factors. There is little information on the preventive use of low-molecular-weight heparin (LMWH) in hospitalized patients with pneumonia. METHODS: We prospectively screened 1067 admissions to our hospital for preventive use of LMWH according to the American College of Chest Physicians (ACCP) guidelines. The analysis included 168 patients with pneumonia (age 74 ± 16 years, 56% men). The primary and secondary outcomes were treatment with LMWH in eligible patients and LMWH use according to guidelines (daily dose, duration of treatment). RESULTS: LMWH use was indicated in 126 (75%) patients and 119 (94%) were actually treated. In 41% of patients treatment was according to the ACCP guidelines. The dose and duration of LMWH treatment were appropriate in 61% and 66% of patients, respectively. Non-use of LMWHs was not associated with clinical and demographic characteristics. Adverse effects included bleeding (N = 7) and thrombocytopenia (N = 2) but were not associated with fatality. Prolonged treatment with LMWH was associated with adverse effects (P < 0.05). CONCLUSIONS: Implementation of LMWH prophylaxis for venous thromboembolism in hospitalized patients with pneumonia reached 94%. Adherence to ACCP guidelines was complete in 41% of patients. Prolonged treatment with LMWH was associated with non-fatal adverse effects, which calls for timely withdrawal of LMWH once no longer indicated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anaya DA, Nathens AB (2005) Thrombosis and coagulation: deep vein thrombosis and pulmonary embolism prophylaxis. Surg Clin North Am 85: 1163–1177
Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, et al (2004) Risk factors for venous thromboembolism in hospitalized patients with acute medical illness. Analysis of the MEDENOX study. Arch Intern Med 164: 963–968
Scaglione L, Piobbici M, Pagano E, Ballini L, Tamponi G, Ciccone G (2005) Implementing guidelines for venous thromboembolism prophylaxis in a large Italian teaching hospital: lights and shadows. Haematologica 90: 678–684
Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al (2004) Prevention of venous thromboembolism. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126: 338S–400S
Pabinger I, Eichinger S, Minar E, Niessner H (2007) Austrian guidelines for prophylaxis of venous thromboembolism. Wien Klin Wochenschr 119: 739–746
Rahim SA, Panju A, Pai M, Ginsberg J (2003) Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review. Thromb Res 111: 215–219
Amin A, Stemkowski S, Lin J, Yang G (2007) Thromboprophylaxis rates in US medical centers: success or failure? J Thromb Haemost 5: 1610–1616
Morgan T, Mrhar A, Kosnik M, Veternik-Debeljak A (2004) Analysis of thromboprophylaxis with low-molecular-weight heparins (LMWH) in medical patients. In: Zidarn M, Kosnik M, Zdolsek S (eds) Abstracts of the 3rd Slovenian Congress of Pneumology and Allergology and 1st Slovenian Congress of Respiratory Nursing; Oct 20–22, 2004; Portoroz. Golnik: Bolnisnica KOPA, 49 [Abstract]
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461–470
Tapson VF, Decousus H, Pini M, Chong BH, Froehlich JB, Monreal M, et al (2007) Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients. Findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest 132: 936–945
Anderson FA Jr, Zayaruzny M, Heit JA, Fidan D, Cohen AT (2007) Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol 82: 777–782
Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, et al (2008) Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 371: 387–394
Masroujeh R, Shamseddeen W, Isma'eel H, Otrock ZK, Khalil IM, Taher A (2008) Underutilization of venous thromboembolism prophylaxis in medical patients in a tertiary care center. J Thromb Thrombolysis 26: 138–141
Leizorovicz A, Cohen AT, Turpie AGG, Olsson CG, Vaitkus PT, Goldhaber SZ (2004) Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 110: 874–879
Douketis DD (2008) Prevention of venous thromboembolism in hospitalized medical patients: addressing some practical questions. Curr Opin Pulm Med 14: 381–388
Stinnett JM, Pendleton R, Skordos L, Wheeler M, Rodgers GM (2005) Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates. Am J Hematol 78: 167–172
Stark JE, Kilzer JW (2004) Venous thromboembolic prophylaxis in hospitalized medical patients. Ann Pharmacother 38: 36–40
Lainščak M, Cleland JGF, Lenzen MJ, Follath F, Komajda M, Swedberg K (2007) International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey. Eur J Heart Fail 9: 292–299
Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U, for the EUROASPIRE Study Group (2009) Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II and III surveys in eight European countries. Lancet 373: 929–940
Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, et al (1999) A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 341: 793–800
Peterman CM, Kolansky DM, Spinler SA (2006) Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study. Pharmacotherapy 26: 1086–1090
Schuler J, Dückelmann C, Beindl W, Prinz E, Michalski T, Pichler M (2008) Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria. Wien Klin Wochenschr 120: 733–741
Lainscak M, Horvat A, Keber I (2003) The management of patients with heart failure in Slovenian community hospital: what has changed from 1997 to 2000? Wien Klin Wochenschr 115: 334–339
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jancar, P., Morgan, T., Mrhar, A. et al. Venous thromboembolism prophylaxis in hospitalized patients with pneumonia: a prospective survey. Wien Klin Wochenschr 121, 318–323 (2009). https://doi.org/10.1007/s00508-009-1173-z
Issue Date:
DOI: https://doi.org/10.1007/s00508-009-1173-z